^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    Immunotherapy

    Apply
    Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC (NCT04506567)
    Phase 1/2
    Weill Medical College of Cornell University
    Recruiting
    Last update posted :
    08/28/2023
    Initiation :
    08/18/2020
    Primary completion :
    06/30/2025
    Completion :
    06/30/2027
    CYP17A1
    |
    Ac-225 rosopatamab tetraxetan (CONV01-α)